Accessibility Menu
Iradimed Corporation logo

Iradimed Corporation(NASDAQ) IRMD

Market Cap$1.22BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2014)+957%
5 Year+197%
1 Year+58%
1 Month-7%
$91.06
-4.36%
-4.15Today
After hours$90.70-$0.36 (-0.40%)
Iradimed Corporation last closing stock price
MetricPriceDate
Last closeUSD 90.862026-07-31
Iradimed Corporation stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-3.84%USD 94.492026-07-24
1 month-7.32%USD 98.042026-07-01
3 month+4.5%USD 86.952026-05-01
Year to date-6.2%USD 96.872025-12-31
1 year+57.91%USD 57.542025-07-31
3 year+111.11%USD 43.042023-08-01
5 year+196.55%USD 30.642021-07-30
Since inception+956.55%USD 9.012014-07-16

Iradimed Corporation Financials at a Glance

Market Cap

$1.22BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$86.34M

Net Income (TTM)

$23.05M

EPS (TTM)

$1.84

P/E Ratio

51.86

Dividend

$0.74

Beta (Volatility)

0.91 (Low)

Price

$91.06

Volume

308,081

Open

$97.74

Previous Close

$90.86

Daily Range

$89.51 - $97.74

52-Week Range

$58.70 - $107.90

Estimated Earnings Date

Jul 31, 2026

IRMD: Motley Fool Moneyball Superscore

77

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Iradimed Corporation

IRADIMED CORPORATION is a specialized medical device company, providing Magnetic Resonance Imaging (MRI) compatible devices. Established in 1992, the company designs, manufactures, and sells non-magnetic medical equipment, ensuring safety during MRI procedures. IRADIMED is known for its unique solutions like the MRidium 3860+ IV infusion pump and the 3880 patient monitoring system, setting it apart within the healthcare industry.

Products and Services

MRidium 3860+ MRI Compatible IV Infusion Pump System

IRadimed 3880 MRI Compatible Patient Vital Signs Monitoring System

3600 FMD1 with Remote Alarm Logging Unit for ferromagnetic detection

Proprietary disposable IV tubing sets and accessories

Comprehensive service agreements and support for their devices

What Makes IRADIMED CORPORATION Special

IRADIMED CORPORATION stands out due to its dedication to innovation in MRI-compatible medical devices. Unlike traditional devices, theirs are non-magnetic, preventing interference and enhancing patient safety during MRI scans. This focus on precision engineering in a niche market gives them a distinct competitive advantage.

Five Things You Need to Know

The MRidium 3860+ is currently the only non-magnetic IV infusion pump designed for MRI settings.

IRADIMED also provides the 3880 monitor, which safely tracks vital signs within MRI environments.

They sell primarily to hospitals and acute care facilities in over 80 countries.

The company generated $65.6 million in revenue with a 30.5% operating profit margin in 2023.

Roger Susi, the founder, is a pioneer in MRI-compatible technology, bolstering the company's leadership in the field.

AI Generated • Apr 16, 2026

Industry

Healthcare Equipment and Supplies

Employees

166

CEO

Roger Susi

Headquarters

Orlando, FL 32708, US

IRMD Financials

Key Financial Metrics (TTM)

Gross Margin

75.86%

Operating Margin

31.91%

Net Income Margin

26.70%

Return on Equity

23.45%

Return on Capital

27.63%

Return on Assets

20.05%

Earnings Yield

1.93%

Dividend Yield

0.78%

Payout Ratio

68.66%

Stock Overview

Market Cap

$1.22BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

12.78M

Volume

308.08K

Avg. Volume

135.47K

Financials (TTM)

Gross Profit

$65.50M

Operating Income

$27.55M

EBITDA

$30.70M

Operating Cash Flow

$27.14M

Capital Expenditure

-$2.21M

Free Cash Flow

$24.93M

Cash & ST Invst.

$59.08M

Total Debt

$0.00

Iradimed Corporation Performance Analysis

Iradimed Corporation annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 53,303,14527.5%
20232023-12-31USD 65,562,29623.0%
20242024-12-31USD 73,242,12111.7%
20252025-12-31USD 83,814,00014.4%
Iradimed Corporation sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-303.9%
Q42025-12-317.0%
Q12026-03-31-3.1%
Q22026-06-30-6.9%
Iradimed Corporation annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 1.0237.1%
20232023-12-31USD 1.3533.1%
20242024-12-31USD 1.5011.3%
20252025-12-31USD 1.7516.2%
Iradimed Corporation sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-4.4%
Q42025-12-3116.3%
Q12026-03-31-10.0%
Q22026-06-30-8.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$20.47M

+0.3%

Gross Profit

$15.16M

-5.0%

Gross Margin

74.07%

N/A

Market Cap

$1.22BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$7.33M

N/A

Employees

166

N/A

Net Income

$5.22M

-9.6%

EBITDA

$6.39M

-19.3%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$59.08M

+11.5%

Total Debt

$0.00

N/A

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

-100.0%

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

20.05%

N/A

Return on Invested Capital

26.04%

N/A

Free Cash Flow

$5.76M

+16.9%

Operating Cash Flow

$5.94M

-23.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IARTIntegra LifeSciences Holdings Corporation
$16.65-2.75%
TNDMTandem Diabetes Care, Inc.
$19.50+2.58%
GDRXGoodRx Holdings, Inc.
$3.07-3.15%
CRONCronos Group Inc.
$2.83-2.08%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$200.75+0.03%
AAPLApple
$308.91-0.07%
AMZNAmazon
$271.58+0.15%
INTCIntel
$90.20-0.01%

Questions About IRMD

What is the current price of Iradimed Corporation?

Iradimed Corporation is trading at $90.86 per share.

What is the 52-week range for Iradimed Corporation?

Over the past 52 weeks, Iradimed Corporation has traded between $58.70 and $107.90.

How much debt does Iradimed Corporation have?

As of the most recent reporting period, Iradimed Corporation reported total debt of $0.00.

How much cash does Iradimed Corporation have on hand?

Iradimed Corporation reported $56.37M in cash and cash equivalents in its most recent financial results.

What is Iradimed Corporation’s dividend yield?

Iradimed Corporation currently has a dividend yield of 0.78%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.